Discover our latest publication showcasing the use of AI-powered Scarletred®Vision for the advanced detection and assessment of onychomycosis, a widespread fungal nail infection affecting millions worldwide.

We are happy to announce our attendance at the 5th Inflammatory Skin Disease Summit: The Translational Revolution to present about smart imaging and deep learning for objective psoriasis lesion scoring.

The DP aims to collaborate with pharmaceutical and biotechnology companies by providing access to our customizable software Scarletred®Vision for exploratory or early-stage clinical studies at a more attractive price point.

The popular newspaper Der Standard features the recent milestones of SCARLETRED in the field of teledermatology. With these, SCARLETRED sets the benchmark for AI-Assisted Screening in telemedicine and radiation oncology.

In an interview, specialist Dr. Zikeli discusses the clinical characteristics of atopic dermatitis and why documentation using Scarletred®Vision is an optimal support for diagnosis and progress monitoring.

The 5th Annual Dermatology Drug Development Summit focusing on development and innovation of therapies and research targeting inflammatory skin diseases, returns to Boston for 2021.

The Inflammatory Skin Disease Summit is a jointly organized event by the Icahn School of Medicine at Mount Sinai and the Austrian Academy of Sciences.

Scarletred’s new digital market research solution offers biopharmaceutical and cosmetic companies high-quality, standardized data via Scarletred®Vision, enabling research from home with an easy-to-use kit and mobile app.